A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function

Objectives: To study the prevalence of fungal species in cystic fibrosis (CF) patients over a 16 years period. To examine the impact of Candida albicans (C. albicans), Candida dubliniensis (C. dubliniensis) and Aspergillus fumigatus (A. fumigatus) on lung function. Methods: Observational single-cent...

Full description

Bibliographic Details
Main Authors: Mahasin Al Shakirchi, Lena Klingspor, Peter Bergman, Lena Hjelte, Isabelle de Monestrol
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220303702
id doaj-c2912a51795f40e5979ba92dc2fa708e
record_format Article
spelling doaj-c2912a51795f40e5979ba92dc2fa708e2020-11-25T02:54:40ZengElsevierInternational Journal of Infectious Diseases1201-97122020-07-0196663670A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung functionMahasin Al Shakirchi0Lena Klingspor1Peter Bergman2Lena Hjelte3Isabelle de Monestrol4Stockholm Cystic Fibrosis Centre, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden; Corresponding author. Stockholm CF center K56-58, Barnmottagning, Albatross, Karolinska Universitetssjukhuset Huddinge, 141 86 Stockholm, Sweden.Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, SwedenDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, The Immunodeficiency Unit, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, SwedenStockholm Cystic Fibrosis Centre, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, SwedenStockholm Cystic Fibrosis Centre, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, SwedenObjectives: To study the prevalence of fungal species in cystic fibrosis (CF) patients over a 16 years period. To examine the impact of Candida albicans (C. albicans), Candida dubliniensis (C. dubliniensis) and Aspergillus fumigatus (A. fumigatus) on lung function. Methods: Observational single-center cohort study (2000–2015) including 133 CF patients (ages 6–66 years). Linear mixed models with autoregressive covariance matrix were used. Results: The most common fungus was C. albicans (prevalence 62%) followed by A. fumigatus (22%) and C. dubliniensis (11%). In the initial year of detection, there was no impact of C. albicans, C. dubliniensis or A. fumigatus on lung function. However, one and two years after detection of C. dubliniensis a reduction in percent predicted forced expiratory volume in the first second (ppFEV1) was observed of 3.8% (p = 0.022) and 4.1% (p = 0.017), respectively, compared with CF patients without these findings. Furthermore, patients with positive cultures for any of these fungal species for three consecutive years exhibited a decline in lung function: C. dubliniensis, 7.6% reduction in ppFEV1 (p = 0.001); A. fumigatus, 4.9% (p = 0.007); C. albicans, 2.6% (p = 0.014). The results were adjusted for age, CFTR genotype, chronic and intermittent P. aeruginosa colonization, and numbers of intravenous antibiotic treatments per year. Persistence of C. dubliniensis for three consecutive years was positively correlated to age and erythrocyte sedimentation rate (ESR) (both p = 0.001). Conclusions: Cystic fibrosis patients who were cultured positive for C. dubliniensis, C. albicans or A. fumigatus in sputum exhibited a decline in ppFEV1 over time. The effect was most pronounced for C. dubliniensis.http://www.sciencedirect.com/science/article/pii/S1201971220303702Cystic fibrosisMoldsYeastsCandida albicansCandida dubliniensisAspergillus fumigatus
collection DOAJ
language English
format Article
sources DOAJ
author Mahasin Al Shakirchi
Lena Klingspor
Peter Bergman
Lena Hjelte
Isabelle de Monestrol
spellingShingle Mahasin Al Shakirchi
Lena Klingspor
Peter Bergman
Lena Hjelte
Isabelle de Monestrol
A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function
International Journal of Infectious Diseases
Cystic fibrosis
Molds
Yeasts
Candida albicans
Candida dubliniensis
Aspergillus fumigatus
author_facet Mahasin Al Shakirchi
Lena Klingspor
Peter Bergman
Lena Hjelte
Isabelle de Monestrol
author_sort Mahasin Al Shakirchi
title A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function
title_short A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function
title_full A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function
title_fullStr A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function
title_full_unstemmed A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function
title_sort 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: candida dubliniensis was associated with a decline in lung function
publisher Elsevier
series International Journal of Infectious Diseases
issn 1201-9712
publishDate 2020-07-01
description Objectives: To study the prevalence of fungal species in cystic fibrosis (CF) patients over a 16 years period. To examine the impact of Candida albicans (C. albicans), Candida dubliniensis (C. dubliniensis) and Aspergillus fumigatus (A. fumigatus) on lung function. Methods: Observational single-center cohort study (2000–2015) including 133 CF patients (ages 6–66 years). Linear mixed models with autoregressive covariance matrix were used. Results: The most common fungus was C. albicans (prevalence 62%) followed by A. fumigatus (22%) and C. dubliniensis (11%). In the initial year of detection, there was no impact of C. albicans, C. dubliniensis or A. fumigatus on lung function. However, one and two years after detection of C. dubliniensis a reduction in percent predicted forced expiratory volume in the first second (ppFEV1) was observed of 3.8% (p = 0.022) and 4.1% (p = 0.017), respectively, compared with CF patients without these findings. Furthermore, patients with positive cultures for any of these fungal species for three consecutive years exhibited a decline in lung function: C. dubliniensis, 7.6% reduction in ppFEV1 (p = 0.001); A. fumigatus, 4.9% (p = 0.007); C. albicans, 2.6% (p = 0.014). The results were adjusted for age, CFTR genotype, chronic and intermittent P. aeruginosa colonization, and numbers of intravenous antibiotic treatments per year. Persistence of C. dubliniensis for three consecutive years was positively correlated to age and erythrocyte sedimentation rate (ESR) (both p = 0.001). Conclusions: Cystic fibrosis patients who were cultured positive for C. dubliniensis, C. albicans or A. fumigatus in sputum exhibited a decline in ppFEV1 over time. The effect was most pronounced for C. dubliniensis.
topic Cystic fibrosis
Molds
Yeasts
Candida albicans
Candida dubliniensis
Aspergillus fumigatus
url http://www.sciencedirect.com/science/article/pii/S1201971220303702
work_keys_str_mv AT mahasinalshakirchi a16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction
AT lenaklingspor a16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction
AT peterbergman a16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction
AT lenahjelte a16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction
AT isabelledemonestrol a16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction
AT mahasinalshakirchi 16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction
AT lenaklingspor 16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction
AT peterbergman 16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction
AT lenahjelte 16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction
AT isabelledemonestrol 16yearretrospectivestudyonfungalprevalenceanddiversityinpatientswithcysticfibrosiscandidadubliniensiswasassociatedwithadeclineinlungfunction
_version_ 1724719553503559680